Does GOLIMUMAB Cause Lung neoplasm malignant? 177 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Lung neoplasm malignant have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.3% of all adverse event reports for GOLIMUMAB.
177
Reports of Lung neoplasm malignant with GOLIMUMAB
0.3%
of all GOLIMUMAB reports
23
Deaths
44
Hospitalizations
How Dangerous Is Lung neoplasm malignant From GOLIMUMAB?
Of the 177 reports, 23 (13.0%) resulted in death, 44 (24.9%) required hospitalization, and 6 (3.4%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 177 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which GOLIMUMAB Alternatives Have Lower Lung neoplasm malignant Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN